Navigation Links
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Date:11/15/2010

11; a global burdenIt is estimated that as many as five million Americans have heart failure, with 400,000-500,000 new cases/year; the diagnosis carries a mortality rate that exceeds many cancers. Heart failure ranks among the most costly chronic conditions in developed countries, with the burden being greatest among the elderly. Heart failure hospitalization represents a major burden on the healthcare system both in the U.S. and the rest of the world.

Given this rapidly increasing incidence of heart failure and relative shortage of novel therapies for diagnosis, a new strategy of care utilizing existing therapies, including the intention to not only address symptoms, but also to lower NT-proBNP concentrations with the goal of reducing risk in parallel, would not only contribute to better patient outcomes, but also likely reduce healthcare costs.

About the Roche sponsored PROTECT studyPROTECT, a prospective randomized trial comparing a strategy of aggressive heart failure therapy guided by levels of a cardiac hormone—amino-terminal pro-B type natriuretic peptide (NT-proBNP)—versus standard heart failure treatment without NT-proBNP guidance has been enrolling subjects in the Heart Center at the Massachusetts General Hospital since 2006.  In December 2009 the promising results of the interim analysis supported the early closure of the study.

Besides the primary endpoint of total cardiovascular events over a one year period, other endpoints in PROTECT will include effects of NT-proBNP guidance on quality of life, effect of NT-proBNP guided care on cardiac structure and function, and overall costs of care.  Publication of the results is expected in the next few months.

About NT-proBNPTests for NT-proBNP, a cardiac hormone that is released into the blood when the heart wall is stretched, are developed and marketed by Roche. NT-proBNP was approved by the U.S. Food and Drug Administration (FDA) as an objective marker
'/>"/>

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs
2. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
3. Guided Delivery Systems, Inc. Successfully Treats First Patient with Mitral Regurgitation
4. Advanced Image-Guided Surgery Technology From BrainLAB Now Available in New York State
5. Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound
6. MR-Guided Focused Ultrasound Symposium Announces Sponsors
7. Western European Market for Image-guided and Robot-assisted Surgery
8. Varian Medical Systems and IMRIS to Co-Develop Revolutionary New MR-Guided Radiation Therapy System
9. Varian Medical Systems Introduces New TrueBeam™ System for Image-Guided Radiotherapy and Radiosurgery to Clinicians in Asia at AOCMP in Taipei, Taiwan
10. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
11. Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... First quarter overview: , Revenues of $47.5 million, ... Diluted EPS of $0.21, up 50% over last year,s ... market revenues of $7.2 million, up 20% over last ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... (Nasdaq: ERES ), a global provider of ... device industries, today announced that Michael McKelvey will be ... Officer and a director of ERT.  The Company,s Board ...  Dr. McKelvey will continue in his current position until ...
... Sept. 10 Covance Inc. (NYSE: CVD ) ... Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 ... presentation at www.covance.com .  In order to register and ... Covance, with headquarters in Princeton, New Jersey, is ...
Cached Medicine Technology:ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 2ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 3
(Date:7/25/2014)... 25, 2014 The American Brain Tumor ... Talent Development Trainer of Distinguished Events, and Corporate and ... American Cancer Society, will be joining the ABTA in ... Ward will oversee the roll out of a nationwide ... , The recently launched volunteer network will provide the ...
(Date:7/25/2014)... Chicago, IL (PRWEB) July 25, 2014 “You ... of more than 500 people and their loved ones across ... Association (ABTA), a brain tumor diagnosis is typically met with ... learn a new and difficult vocabulary, and make critical decisions ... a brain tumor diagnosis is accompanied by a sense of ...
(Date:7/25/2014)... IL (PRWEB) July 25, 2014 Today, nearly ... tumor, and yet, when it comes to pinpointing causes or ... now, we don’t know who, we don’t know when, and ... M. Wilson, MNA, president & CEO, American Brain Tumor Association. ... the American Brain Tumor Association funds research to pursue answers ...
(Date:7/25/2014)... July 25, 2014 The North America Artificial ... in North America with analysis and forecast of revenue. The ... from around $4.7 billion in 2013 to around $7 billion ... 2018. , Browse through the TOC of North America ... analysis provided. This also provides a glimpse of the segmentation ...
(Date:7/25/2014)... 25, 2014 The report, "Wireless ... Wi-Fi, Wireless Gigabit Alliance, Access Points, Routers, Residential ... Technology Roadmap and Analysis (2014 - 2019)," provides ... overall market, segmented by WiGig enabled products, and ... segments of the WiGig market, and provides the ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 2Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 2Health News:Brain Tumor Causes and Risk Factors Elude Scientists 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 4Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Artificial Lift Services Market is Expected to Reach $7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Wireless Gigabit (WiGig) Market Projected to $10.53 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Wireless Gigabit (WiGig) Market Projected to $10.53 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wireless Gigabit (WiGig) Market Projected to $10.53 Billion by 2019 - New Report by MarketsandMarkets 4
... Jan. 10 Beginning Sunday, Jan. 10 and continuing through ... Disease Control (CDC) to promote National Influenza Vaccination Week. , ... nationwide effort to remind individuals it,s not too late to ... a serious disease. The Centers for Disease Control and Prevention ...
... ... (with over 65 clients in 24 states) announced today that several radiology practices in the ... Santa Fe Imaging in Santa Fe, NM, have signed contracts for billing and practice management ... Columbus, ...
... ... running plastic surgery practice in the nation is launching an expansive new ... Plastic Surgical Group, PC, a practice offering reconstructive and cosmetic surgery ... to provide web visitors with a thorough virtual tour of its facilities ...
... WASHINGTON, Jan. 8 Speaker Nancy Pelosi released the following statement on ... b y the Center for American Progress that ... over the next decade than would be created without reform. The report finds ... States by about 250,000 to 400,000 per year over the coming decade. ...
... ... , Health and Development Groups Applaud Clinton ... coalition of organizations representing millions of Americans applauded today,s statement by Secretary ... consensus that achieving universal access to reproductive health is critical for individual ...
... , , SILVER SPRING, Md., Jan. ... to stop producing and distributing its medical products used in ... compliance with FDA quality standards. The products are considered to ... review and approval for safety and effectiveness. The agreement was ...
Cached Medicine News:Health News:Highmark Supports National Influenza Vaccination Week 2Health News:Highmark Supports National Influenza Vaccination Week 3Health News:ADVOCATE Announces New Partnerships With Centers in the Western U.S. 2Health News:ADVOCATE Announces New Partnerships With Centers in the Western U.S. 3Health News:Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website 2Health News:Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website 3Health News:Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website 4Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 2Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 3Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 4Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 5Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 6Health News:U.S. Government Rejoins Worldwide Consensus on Reproductive Health 7Health News:FDA Requires Sybaritic, Inc. to Stop Producing Unapproved Medical Devices 2Health News:FDA Requires Sybaritic, Inc. to Stop Producing Unapproved Medical Devices 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: